TrialJHEP reports : innovation in hepatology2026

Evaluation of novel assays of non-ceruloplasmin copper to monitor chelation treatment in patients with Wilson disease.

Peter Ott et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.